Nantkwest inc stock analysis
WitrynaThe high in the last 52 weeks of NantKwest stock was 7.80. According to the current price, NantKwest is 21.92% away from the 52-week high. What are analysts … WitrynaNantKwest Inc NAS :NK (USA) Portfolio $ 32.49 0 (0%) 09:42 AM EST Warning! GuruFocus detected issues with NK. Try a 7-Day Free Trial to check it out. Also Trade In: Volume: - Market Cap $: 3.55B PE Ratio: At Loss Avg Vol (2M): - Enterprise Value $: 3.55B PB Ratio: 0 GF Score: Year: 10Y: -% Above Low: +NaN% Below High: NaN%
Nantkwest inc stock analysis
Did you know?
Witryna11 kwi 2024 · Get The Latest NWG Stock Forecast, Price Target, Dividend Info, Headlines, Short Interest at MarketBeat. ... View NWG analyst ratings or view top … Witryna28 lip 2024 · For NantKwest, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the …
Witryna9 mar 2024 · CULVER CITY, Calif.& EL SEGUNDO, Calif.---- ImmunityBio, Inc. and NantKwest, Inc., today announced the completion of their previously announced 100% stock-for-stock merger. This follows the ... Witryna17 sty 2024 · Currently, NantKwest is a Zacks Rank #3 (Hold) in the Medical - Biomedical and Genetics industry that ranks in the Top 34% of our Zacks Industry Rank. Over the last 30 days, no analysts have...
Witryna23 gru 2024 · NantKwest的haNK 是经过工程改造的NK细胞，起源于NantKwest专有的NK-92（aNK）主细胞库，经过工程改造后使其表达高亲和力CD16受体，从而使其可以直接结合先前与癌细胞结合的单克隆抗体，通过抗体介导的ADCC作用来增强对肿瘤细胞的杀伤作用。 NantKwest的PD-L1.t-haNK 是人类衍生的同种异体NK细胞系，经过工程 … WitrynaMar 6, 2024. $ 38.38. 18.13%. The NantKwest, Inc. stock price forecast for the next 30 days is a projection based on the positive/negative trends in the past 30 …
Witryna24 lut 2024 · NantKwest Transaction As previously announced on December 21, 2024, ImmunityBio entered into an agreement to combine in a stock-for-stock transaction with NantKwest. The combination, which is expected to close in the first half of 2024, will create a leading immunotherapy and cell therapy company focused on oncology and … エクセル 高さを揃える 一括Witryna10 sty 2024 · I nvestors in NantKwest, Inc.NK need to pay close attention to the stock based on moves in the options market lately. That is because the Jul 19, 2024 $2.50 … エクセル 黒い十字Witryna9 mar 2024 · CULVER CITY & EL SEGUNDO, Calif., March 9, 2024 — ImmunityBio, Inc. and NantKwest, Inc. (NASDAQ: NK), today announced the completion of their previously announced 100% stock-for-stock merger. This follows the satisfaction of all … エクセル 黒い画面Witryna11 kwi 2024 · The K Cells market research report is a comprehensive analysis of a specific market and its various elements. In order to ensure that the K Cells report is focused and provides relevant... エクセレージWitryna16 lip 2024 · NASDAQ:NK NantKwest - NK Stock Forecast, Price & News Notice: This company has been marked as potentially delisted and may not be actively trading. … panalivio icaWitryna17 sty 2024 · Currently, NantKwest is a Zacks Rank #3 (Hold) in the Medical - Biomedical and Genetics industry that ranks in the Top 34% of our Zacks Industry Rank. Over the last 30 days, no analysts have... pan allotment applicationWitrynaImmunitybio Inc (IBRX) NASDAQ Add to Watchlist 1.80 -0.02 ( -1.15 %) 11:39:30 - Real-time Data. Currency in USD ( Disclaimer) Volume: 1,346,433 Day's Range: 1.75 - 1.88 52 wk Range: 1.21 - 7.80... エクセル 黒い部分